Latest Leadership News

Bapcor Limited has postponed its half-year financial results release to no later than 27 February 2026 and is seeking an extension of its trading suspension, hinting at a potential capital raising.

Eminence Minerals Limited has issued 2.7 million unquoted CEO performance rights as part of a new executive appointment, utilising its 15% placement capacity without shareholder approval.

Orcoda Limited has reported strong half-year FY26 results, showcasing significant growth in revenue, EBITDA, and recurring revenue as it advances its AI-powered transport ecosystem solutions.

Papyrus Australia Limited reported a reduced half-year loss and marked a significant commercial milestone with a $4.2 million supply contract, advancing its transition from technology development to early-stage commercialisation.

Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.

Santana Minerals has completed a substantial A$113 million unconditional placement, with plans underway to seek shareholder approval for an additional $17 million capital raise. The move signals a significant boost to the company’s financial firepower as it advances its mining ambitions.

Scentre Group reported robust 2025 results with a 4.9% rise in Funds From Operations and record customer visitation, while progressing key sustainability and growth initiatives.

Scentre Group has reported a robust 2025 financial year with Funds From Operations rising 4.9% and distributions up 3.4%, underpinned by record occupancy and strong customer engagement. The Group also advanced its sustainability agenda, exceeding interim net zero targets and progressing major redevelopment projects.

OncoSil Medical has reported record dose sales and cash receipts in the first half of FY26, supported by encouraging clinical trial results and expanded European market penetration.

Propel Funeral Partners reported a 6.2% rise in statutory net profit to $12.5 million for the half-year ended December 2025, supported by strategic acquisitions in New Zealand and a refinancing of its senior debt. The company also declared a 7.5 cent fully franked interim dividend.

Woodside Energy Group Ltd reported record production and a net profit after tax of $2.7 billion in 2025, advancing key LNG and ammonia projects while achieving its 15% emissions reduction target.

Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.